首页> 外文期刊>Bulletin of experimental biology and medicine >Insulin-Like Growth Factors (IGF) and IGF-Binding Proteins (IGFBP) in the Serum of Patients with Ovarian Tumors
【24h】

Insulin-Like Growth Factors (IGF) and IGF-Binding Proteins (IGFBP) in the Serum of Patients with Ovarian Tumors

机译:卵巢肿瘤患者血清中的胰岛素样生长因子(IGF)和IGF结合蛋白(IGFBP)

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

IGF-1, IGF-2, and IGFBP-1,2,3 were assayed in blood serum of patients with malignant ovarian tumors (n=44), borderline ovarian tumors (n=11), and benign ovarian tumors (n=12) as well as in healthy women (n=33). In blood serum of patients with malignant ovarian tumors, the level of IGF-1 was lower and IGFBP-1 was higher than in other groups. In patients with malignant and borderline ovarian tumors, the level of IGFBP-2 was higher than in healthy women and in patients with benign ovarian tumors. There was no correlation between most examined parameters and the clinical and morphological peculiarities of ovarian tumors. The study revealed IGF/IGFBP imbalance in patients with malignant ovarian tumor and showed that IGFBP-2 proved to be a potential diagnostic serological marker w with 90% sensitivity and 90% specificity.
机译:在患有恶性卵巢肿瘤(n = 44),交界性卵巢肿瘤(n = 11)和卵巢良性肿瘤(n = 12)的患者血清中检测了IGF-1,IGF-2和IGFBP-1,2,3 )以及健康女性(n = 33)。在卵巢恶性肿瘤患者的血清中,IGF-1的水平较低,而IGFBP-1的水平高于其他组。在具有恶性和交界性卵巢肿瘤的患者中,IGFBP-2的水平高于健康女性和患有良性卵巢肿瘤的患者。大多数检查参数与卵巢肿瘤的临床和形态特征之间没有相关性。该研究揭示了卵巢恶性肿瘤患者的IGF / IGFBP失衡,并表明IGFBP-2被证明是具有90%的敏感性和90%的特异性的潜在的血清学诊断标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号